Cargando…
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
In a study conducted at St Bartholomew's Hospital between 1972 and 1982, using moderately intensive therapy (OPAL/HEAV'D), a low blast count at presentation (less than 10 x 10(9) 1(-1)) and common ALL (C-ALL) phenotype correlated favourably with duration of remission. Fifty-four patients (...
Autores principales: | Rohatiner, A. Z., Bassan, R., Battista, R., Barnett, M. J., Gregory, W., Lim, J., Amess, J., Oza, A., Barbui, T., Horton, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971462/ https://www.ncbi.nlm.nih.gov/pubmed/2206954 |
Ejemplares similares
-
Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
por: Gledhill, R. M., et al.
Publicado: (1983) -
High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.
por: Parikh, P., et al.
Publicado: (1990) -
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011) -
A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979) -
Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)